Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Surgery Partners Inc (NASDAQ: SGRY) closed at $21.07 down -1.17% from its previous closing price of $21.32. In other words, the price has decreased by -$1.17 from its previous closing price. On the day, 0.69 million shares were traded. SGRY stock price reached its highest trading level at $21.36 during the session, while it also had its lowest trading level at $20.92.
Ratios:
For a deeper understanding of Surgery Partners Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.98 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.82. For the most recent quarter (mrq), Quick Ratio is recorded 1.65 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 2.07 whereas as Long-Term Debt/Eq ratio is at 1.99.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BofA Securities on December 16, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On October 14, 2024, UBS started tracking the stock assigning a Buy rating and target price of $38.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 14 ’25 when Baldock Jennifer sold 612 shares for $23.94 per share. The transaction valued at 14,651 led to the insider holds 236,047 shares of the business.
Burkhalter Danielle sold 74 shares of SGRY for $1,760 on Mar 14 ’25. The Chief Human Resources Officer now owns 44,839 shares after completing the transaction at $23.78 per share. On Mar 14 ’25, another insider, Webb William Trenton, who serves as the American Group President of the company, sold 138 shares for $23.70 each. As a result, the insider received 3,271 and left with 74,521 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGRY now has a Market Capitalization of 2688805888 and an Enterprise Value of 7959122432. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.86 while its Price-to-Book (P/B) ratio in mrq is 1.50. Its current Enterprise Value per Revenue stands at 2.556 whereas that against EBITDA is 12.696.
Stock Price History:
The Beta on a monthly basis for SGRY is 1.97, which has changed by -0.13894564 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, SGRY has reached a high of $33.97, while it has fallen to a 52-week low of $19.50. The 50-Day Moving Average of the stock is -12.21%, while the 200-Day Moving Average is calculated to be -19.75%.
Shares Statistics:
For the past three months, SGRY has traded an average of 1.34M shares per day and 1281270 over the past ten days. A total of 127.11M shares are outstanding, with a floating share count of 75.59M. Insiders hold about 40.77% of the company’s shares, while institutions hold 72.33% stake in the company. Shares short for SGRY as of 1743379200 were 10186093 with a Short Ratio of 7.58, compared to 1740700800 on 9978610. Therefore, it implies a Short% of Shares Outstanding of 10186093 and a Short% of Float of 17.49.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
